Position in GYRE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,714,470
New position
Shares Held
3,750,299
first reported quarter
Ownership
3.36%
of shares outstanding
% of Portfolio
2.07%
of 13F equity value
Holder Rank
#1
of 60 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HSG Holding Ltd holds $70,756,776 across 6 Biotechnology names. GYRE ranks #1 (34.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GYRE |
Gyre Therapeutics, Inc.
This page
|
3,750,299 | $24,714,470 | |
| 2 | AVBP |
ArriVent BioPharma, Inc.
|
663,308 | $23,043,319 | |
| 3 | GPCR |
Structure Therapeutics Inc.
|
266,062 | $14,279,547 | |
| 4 | ADAG |
Adagene Inc.
|
1,343,364 | $5,642,128 | |
| 5 | LYEL |
Lyell Immunopharma, Inc.
|
152,299 | $2,139,800 | |
| 6 | BRNS |
Barinthus Biotherapeutics plc.
|
1,420,473 | $937,512 |
All Filings in GYRE
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,714,470 | 3,750,299 | Shares | Defined | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||